Sort
48,018 grants matching “immunotherapy”
EASTERN COOPERATIVE ONCOLOGY GROUP
$411,364University Of Pennsylvania · U10 · FY2001 · CA
Target-specific inhibition and activation of protein tyrosine phosphatases
$411,330Anthony C Bishop · Amherst College · R15 · FY2021 · GM
Development of mAb immunotherapy for genetically modified plague
$411,313James B Bliska · Columbia University Health Sciences · U54 · FY2011 · AI
Regulation of host immunity to impact virus persistence
$411,274Bumsuk Hahm · University Of Missouri-Columbia · R01 · FY2022 · AI
NK cell responses to JC polyomavirus
$411,250Chen Sabrina Tan · Beth Israel Deaconess Medical Center · R01 · FY2021 · NS
NK cell responses to JC polyomavirus
$411,250Chen Sabrina Tan · Beth Israel Deaconess Medical Center · R01 · FY2020 · NS
NK cell responses to JC polyomavirus
$411,250Chen Sabrina Tan · Beth Israel Deaconess Medical Center · R01 · FY2022 · NS
Lineage Specific Effects of IL10 In Autoimmunity
$411,250Terrence L Geiger · St. Jude Children'S Research Hospital · R56 · FY2013 · AI
Cellular Mechanisms of PTLD in Transplant Recipients
$411,227Olivia M Martinez · Stanford University · R01 · FY2010 · AI
Spatial and temporal tumor-immune co-evolution and interactions that model lung adenocarcinoma development
$411,223Humam Kadara · University Of Tx Md Anderson Can Ctr · U01 · FY2024 · CA
MATCHMAKERS: Solving T-cell receptor recognition and design via integrated high-throughput screening and structural, functional and computational approaches
$411,201Stephen J Elledge · Brigham And Women'S Hospital · OT2 · FY2025 · CA
Cancer and Leukemia Group B
$411,171Dana-Farber Cancer Institute · U10 · FY2004 · CA
EGFRvIII-targeted Bispecific T cell Engagers for brain tumors
$411,170John H Sampson · Duke University · R01 · FY2013 · NS
Biomimetic Zwitterionic Functional Materials for Immunomodulation
$411,138Jiang Shaoyi · Cornell University · · FY2020 · MPS
Contribution of the cutaneous APC network to melanoma progression and therapy.
$411,038Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · CA
Collaborative Innate-Adaptive Immune Regulation of Tumor Progression
$410,978Matthew F Krummel · University Of California, San Francisco · U01 · FY2012 · CA
Developing a Translation Pipeline for VHL Mutant Malignancies
$410,974David McDermott · Beth Israel Deaconess Medical Center · U01 · FY2020 · CA
TLR5 signaling as a conserved mechanism of impaired anti-tumor immunity
$410,973Melanie R Rutkowski · University Of Virginia · R01 · FY2025 · CA
Understanding the Mechanism of Mucosal Immunotherapy
$410,941Arvil Wesley Burks · Duke University · R01 · FY2010 · AI
Targetable Immune Evasion Pathways in Hodgkin Lymphoma
$410,899Margaret A Shipp · Dana-Farber Cancer Inst · R01 · FY2016 · CA
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
$410,890Cancer Therapy And Research Center · U10 · FY2005 · CA
Targeted activation of autoimmune checkpoints in B cell malignancies
$410,875Markus Mãschen · Beckman Research Institute/City Of Hope · R01 · FY2017 · CA
Targeted activation of autoimmune checkpoints in B cell malignancies
$410,875Markus Mãschen · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
Immunoengineered nanotechnology for targeted expansion of regulatory T cells
$410,855Jamie Berta Spangler · Johns Hopkins University · R01 · FY2023 · EB
Binding and Presentation of Lipid Antigens by CD1
$410,850Steven A Porcelli · Albert Einstein College Of Medicine · R01 · FY2010 · AI